It’s about time. With as many advances as we’ve seen recently in women’s health — from endometriosis being able to be diagnosed without surgery, to completely rethinking and renaming PCOS, now more accurately, PMOS — we still have a long way to go in terms of understanding how medications affect the sexes differently. It’s often … Read more
It’s a battle of the sexes. The diabetes-turned-weight-loss drug Mounjaro has been making headlines for its effectiveness at helping people shed pounds, even delivering better results than Ozempic. And when it comes to who loses more weight on the blockbuster drug, research has found one group comes out on top. It’s a battle of the … Read more
July 22 (Reuters) – The risk of hair loss in patients taking GLP-1 drugs for obesity or diabetes, while low, is higher than with other diabetes drugs, new studies suggest. At two or more years after starting treatment, the odds of a new diagnosis of alopecia in GLP-1 users were 37 percent higher than in … Read more
Before heading overseas, American travelers are warned to double-check their bags for one item that could lead to hefty fines or even prison time. US officials are reminding travelers that bringing cannabis products across international borders remains illegal in many countries — following a new customs policy in Thailand that significantly increases penalties for violators. In June … Read more
A recent study suggests GLP-1-related weight loss may improve some women’s relationships and employment status. Rebecca Diamond, professor of economics at Harvard University in Boston, independently published research that found an association between weight-loss medications and a change in women’s social and economic outcomes. Diamond used the Understanding America Study, a panel survey from the University of Southern California, … Read more
Women who use Depo-Provera face a higher risk of developing a slow-growing brain tumor, known as a meningioma, while the contraceptive’s maker, Pfizer, faces hundreds of lawsuits claiming that it was aware of the potential risks. The brand name for depot medroxyprogesterone acetate (DMPA), Depo-Provera, contains the synthetic progestin hormone and is used by roughly 1 in 4 … Read more
GLP-1 meds could be stifling your senses. The drugs, originally developed to manage diabetes, have exploded in use after being approved to treat obesity, with as many as 1 in 8 adults currently taking the jab. But those lean-seeking masses could end up losing more than just their apple bottoms, as new research suggests the meds can … Read more
Definium Therapeutics said a single dose of its LSD-based experimental pill significantly reduced symptoms of major depression in patients in a late-stage trial, sending its shares soaring 55% to a more than four-year high on Monday. The experimental drug helped patients record significantly lower scores on a standard depression scale than those on placebo after six weeks, … Read more
Against a fiery background with an African rhino pictured blazing forward, this pill advertises “TIME. SIZE. STAMINA.” It’s a common sight at bodegas and gas stations, hanging behind the clerk between the cigarettes and phone chargers. There are dozens of brands making these gas station sex pills. Are they totally fake? Not exactly. At best, … Read more
Taking a shot at crime? GLP-1 medications like Ozempic and Mounjaro could be helping people make better choices — and not just with their food. A new study published today in the journal Criminology suggests these medications can actually make people less likely to act violently. Photographee.eu – stock.adobe.com Though GLP-1 agonists are prescribed to … Read more
Millions of Medicare patients will be eligible for GLP-1 weight-loss drugs like Ozempic and Wegovy at a cut-rate $50 per month under an upcoming government program. Up to 14 million Medicare recipients are overweight and could qualify for the discounted drug program — known as the Medicare GLP-1 Bridge — which rolls out July 1 … Read more
GLP-1s seem to be fertile ground for a variety of health benefits. Recently, research has suggested the weight loss drugs might also help reduce risk of dementia and depression, help with ADHD symptoms and even reduce risks of breast cancer. Now, new findings suggest GLP-1s — popularly sold under brand names like Ozempic and Mounjaro … Read more
A string of over-the-counter drug-induced deaths is putting care providers and state officials on high alert. In the past two months, three children in Connecticut have allegedly died in connection to overdoses of diphenhydramine, the active ingredient in Benadryl. The fatalities were confirmed earlier this week by the state Office of the Child Advocate (OCA). … Read more
You may yet be able to lean out without losing out, as a new drug could save GLP-1 users from the flat fate of “Ozempic butt.” A symptom of rapid weight loss, Ozempic butt is characterized by a sudden loss of volume and muscle in key areas, leaving users looking and feeling deflated. And Americans … Read more
GLP-1 drugs aren’t just reducing weight — they may also be reducing the chances of developing one of the most common and deadliest cancers for women. Blockbuster weight loss drugs like Ozempic and Wegovy have been linked to numerous benefits beyond weight loss, such as cutting the risk of obesity-related cancers in half. And new … Read more
Popular glucagon-like peptide-1 (GLP-1) weight-loss drugs may help slow the spread of some cancers, according to new research to be presented at a major medical conference. Research led by Cleveland Clinic found that the medications may reduce the spread of several obesity-related cancers, including lung, breast, colorectal and liver cancers. The findings will be presented at the 2026 ASCO … Read more
Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under brand names like Ozempic have helped millions of people lose weight, manage diabetes and improve other health conditions, they are not without risks. Check back for more stories about the lesser-known downsides of … Read more
Twelve-time Olympic medal winning swimmer Ryan Lochte stunned fans this week by announcing he has taken a $30,000-a-year assistant coaching gig with Missouri State University. It’s been a rocky few years for the champion after battling depression so crippling some days he couldn’t even get out of bed, he told The Post in an exclusive … Read more
Just weeks prior to his death, Brandon Clarke was arrested for possession of kratom. The NBA player allegedly had nearly half a pound of it. But what exactly is it? According to Health and Human Services Secretary Robert F. Kennedy Jr., who’s launching a federal crackdown on 7-OH — the synthetic byproduct of the kratom … Read more
A 31-year-old woman has described how her addiction to an easy to access product left her partially paralysed. The use of nitrous oxide, or laughing gas, as a recreational drug has been on the rise since Covid, with inhalation of the chemical compound inducing momentary feelings of euphoria. However, the colloquial name of the gas … Read more